Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News Momentum Movers Short Sales

Anavex Life Sciences (AVXL) Confirms Information in July 27 Press Release Announcing Positive Results from Phase 2a Alzheimer's Trial for ANAVEX 2-73July 29, 2016 9:22 AM FBR Capital Recommends Buying Anavex Life Sciences (AVXL) After Yesterday's WeaknessJuly 28, 2016 7:45 AM GeoInvesting Dances as Anavex Life Sciences (AVXL) DropsJuly 27, 2016 2:15 PM Anavex Life Sciences (AVXL) Continues Plunge Following DataJuly 27, 2016 1:56 PM Anavex Life Sciences (AVXL) Halted on LUDPJuly 27, 2016 1:21 PM Anavex Life Sciences (AVXL) Resumes Trading; Shares Down 25%July 27, 2016 1:14 PM Anavex Life Sciences (AVXL) Halted Again on LUDPJuly 27, 2016 1:07 PM Anavex Presents 31-Week Efficacy Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer’s Patients at AAIC 2016July 27, 2016 1:00 PM